|Bid||26.30 x 800|
|Ask||26.58 x 900|
|Day's Range||25.65 - 26.75|
|52 Week Range||11.15 - 30.38|
|Beta (5Y Monthly)||1.47|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Nov 10, 2010|
|1y Target Est||27.78|
OTTAWA, ON, Jan. 16, 2021 /CNW/ - As the resurgence of COVID-19 activity continues in Canada, we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity.
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") will provide a preliminary update on its fourth-quarter and full-year 2020 financial results and the continued pace of its business recovery from the COVID-19 pandemic tomorrow, Jan. 13, 2021, during a fireside chat at 10 a.m. ET at the 39th Annual J.P. Morgan Healthcare Conference.
LAVAL, QC, Jan. 6, 2021 /CNW/ -- Bausch Health Companies Inc.